Plus news about ALS Investment Fund, Q32 Bio, Akebia Therapeutics, Lynk Pharmaceuticals, Hemay Pharmaceutical and Valneva: 🤝 Angelini Ventures teams…
Read More

Plus news about ALS Investment Fund, Q32 Bio, Akebia Therapeutics, Lynk Pharmaceuticals, Hemay Pharmaceutical and Valneva: 🤝 Angelini Ventures teams…
Read More
Nuclidium’s coin purse is approximately $99 million heavier after the Swiss biotech closed its series B round on Thursday. Unlike…
Read More